MEDINET Co., Ltd. (2370)

Market cap
¥7.9B
P/E ratio
-5.5x
Medinet develops cell processing and regenerative medicine products for hospitals and pharmaceutical companies, offering manufacturing services and facility operations.
Period EndTotal current liabilities (Million JPY)YoY (%)
Sep 30, 2025233-13.32%
Sep 30, 2024269-22.46%
Sep 30, 2023347+24.18%
Sep 30, 2022279+1.56%
Sep 30, 2021275+0.66%
Sep 30, 2020273-16.93%
Sep 30, 2019329-26.39%
Sep 30, 2018447+15.29%
Sep 30, 2017388-68.89%
Sep 30, 20161,246-0.84%
Sep 30, 20151,257-2.30%
Sep 30, 20141,286
AI Chat